Macrophages prevent human red blood cell reconstitution in immunodeficient mice

Institute of Immunology, Hefei National Laboratory for Physical Sciences at Microscale and School of Life Sciences, University of Science and Technology of China, Hefei, China.
Blood (Impact Factor: 10.45). 09/2011; 118(22):5938-46. DOI: 10.1182/blood-2010-11-321414
Source: PubMed


An animal model supporting human erythropoiesis will be highly valuable for assessing the biologic function of human RBCs under physiologic and disease settings, and for evaluating protocols of in vitro RBC differentiation. Herein, we analyzed human RBC reconstitution in NOD/SCID or NOD/SCID/γc(-/-) mice that were transplanted with human CD34+ fetal liver cells and fetal thymic tissue. Although a large number of human CD45- CD71+ nucleated immature erythroid cells were detected in the bone marrow, human RBCs were undetectable in the blood of these mice. Human RBCs became detectable in blood after macrophage depletion but disappeared again after withdrawal of treatment. Furthermore, treatment with human erythropoietin and IL-3 significantly increased human RBC reconstitution in macrophage-depleted, but not control, humanized mice. Significantly more rapid rejection of human RBCs than CD47-deficient mouse RBCs indicates that mechanisms other than insufficient CD47-SIRPα signaling are involved in human RBC xenorejection in mice. All considered, our data demonstrate that human RBCs are highly susceptible to rejection by macrophages in immunodeficient mice. Thus, strategies for preventing human RBC rejection by macrophages are required for using immunodeficient mice as an in vivo model to study human erythropoiesis and RBC function.

Download full-text


Available from: Nico Van Rooijen, Dec 14, 2013
  • Source
    • "We therefore sought to optimize the mouse model used to assess human erythrocyte transfusion. Earlier reports of erythrocyte transfusion into NOG mice suggested the efficacy of using infused PB- RBCs as a decoy (Giarratana et al., 2005, 2011; Jiménez- Díaz et al., 2009) or injecting clodronate-liposomes to deplete macrophages in vivo (Arnold et al., 2011; Hu et al., 2011). We therefore tested the effect of clodronateliposomes on imERYPC circulation in mice pretreated with decoy RBCs. "
    [Show abstract] [Hide abstract]
    ABSTRACT: The lack of knowledge about the mechanism of erythrocyte biogenesis through self-replication makes the in vitro generation of large quantities of cells difficult. We show that transduction of c-MYC and BCL-XL into multipotent hematopoietic progenitor cells derived from pluripotent stem cells and gene overexpression enable sustained exponential self-replication of glycophorin A(+) erythroblasts, which we term immortalized erythrocyte progenitor cells (imERYPCs). In an inducible expression system, turning off the overexpression of c-MYC and BCL-XL enabled imERYPCs to mature with chromatin condensation and reduced cell size, hemoglobin synthesis, downregulation of GCN5, upregulation of GATA1, and endogenous BCL-XL and RAF1, all of which appeared to recapitulate normal erythropoiesis. imERYPCs mostly displayed fetal-type hemoglobin and normal oxygen dissociation in vitro and circulation in immunodeficient mice following transfusion. Using critical factors to induce imERYPCs provides a model of erythrocyte biogenesis that could potentially contribute to a stable supply of erythrocytes for donor-independent transfusion.
    Stem Cell Reports 12/2013; 1(6):499-508. DOI:10.1016/j.stemcr.2013.10.010 · 5.37 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: In this issue of Blood, Hu et al. show that depletion of mouse macrophages enables the development and persistence of human red blood cells (hRBCs) in immunodeficient mouse models. (Figure Presented).
    Blood 11/2011; 118(22):5719-20. DOI:10.1182/blood-2011-09-381152 · 10.45 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: This review assesses the recent progress in xenograft rejection by innate immune responses, with a focus on innate cellular xenoreactivity. Current literature was reviewed for new insights into the role of innate cellular immunity in xenograft rejection. Increasing evidence confirms that vigorous innate immune cell activation is accounted for by a combination of xenoantigen recognition by activating receptors, and incompatibility in inhibitory receptor-ligand interactions. Although both innate humoral and cellular xenoimmune responses are predominantly elicited by preformed and induced xenoreactive antibodies in nonhuman primates following porcine xenotransplantation, innate immune cells can also be activated by xenografts in the absence of antibodies. The latter antibody-independent response will likely persist in recipients even when adaptive xenoimmune responses are suppressed. In addition to xenograft rejection by recipient innate immune cells, phagocytic cells within liver xenografts are also deleterious to recipients by causing thrombocytopenia. Strategies of overcoming innate immune responses are required for successful clinical xenotransplantation. In addition to developing better immunosuppressive and tolerance induction protocols, endeavors towards further genetic modifications of porcine source animals are ultimately important for successful clinical xenotransplantation.
    Current opinion in organ transplantation 01/2012; 17(2):162-7. DOI:10.1097/MOT.0b013e328350910c · 2.88 Impact Factor
Show more